Who
Stuart Essig
President and CEO
Company insider
Files Form 4 as: President and CEO, Integra LifeSciences Holdings; Director, Piper Sandler Companies; Director, IDEXX Laboratories; 10% owner, Dynatronics; Director, Orthofix Medical; Director, SeaSpine Holdings; Director, Accendra Health; Director, St Jude Medical.
In numbers
- Trades disclosed
- 511
- Buys
- 29
- Sells
- 82
- Bought
- $4.8M
- Sold
- $186.0M
- Companies
- 9
- Companies where not an officer
- 8
- First trade
- 31 Dec 2005
- Last trade
- 1 Jun 2026
- Last filed
- 3 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Jun 2026filed 3 Jun 2026 | IART Integra LifeSciences Holdingsoption or derivative · Medical Devices | SEC FORM 4 Code A | —705,468 at $0.00 | filing |
| 1 Jun 2026filed 3 Jun 2026 | IART Integra LifeSciences Holdingsoption or derivative · Medical Devices | SEC FORM 4 Code A | —365,297 at $0.00 | filing |
| 1 Jun 2026filed 3 Jun 2026 | IART Integra LifeSciences Holdingsoption or derivative · Medical Devices | SEC FORM 4 Code A | —705,468 at $0.00 | filing |
| 1 Jun 2026filed 3 Jun 2026 | IART Integra LifeSciences Holdingsoption or derivative · Medical Devices | SEC FORM 4 Code A | —365,297 at $0.00 | filing |
| 20 May 2026filed 21 May 2026 | PIPR Piper Sandler CompaniesCapital Markets & Asset Management | SEC FORM 4 Code A | —1,875 at $0.00 | filing |
| 20 May 2026filed 21 May 2026 | PIPR Piper Sandler CompaniesCapital Markets & Asset Management | SEC FORM 4 Code A | —1,875 at $0.00 | filing |
| 12 May 2026filed 14 May 2026 | IDXX IDEXX Laboratoriesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —525 at $0.00 | filing |
| 12 May 2026filed 14 May 2026 | IDXX IDEXX Laboratoriesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —234 at $0.00 | filing |
| 12 May 2026filed 14 May 2026 | IDXX IDEXX Laboratoriesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —525 at $0.00 | filing |
| 12 May 2026filed 14 May 2026 | IDXX IDEXX Laboratoriesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —234 at $0.00 | filing |
| 4 Feb 2026filed 5 Feb 2026 | PIPR Piper Sandler CompaniesCapital Markets & Asset Management | SEC FORM 4 Code A | —175 at $0.00 | filing |
| 4 Feb 2026filed 5 Feb 2026 | PIPR Piper Sandler CompaniesCapital Markets & Asset Management | SEC FORM 4 Code A | —175 at $0.00 | filing |
| 30 Oct 2025filed 30 Oct 2025 | Dynatronics | SEC FORM 4 Code J | —13,405 | filing |
| 30 Oct 2025filed 30 Oct 2025 | Dynatronics | SEC FORM 4 Code J | —2,690 | filing |
| 1 Oct 2025filed 3 Oct 2025 | Dynatronics | SEC FORM 4 Code J | —960,655 | filing |
| 1 Oct 2025filed 3 Oct 2025 | Dynatronics | SEC FORM 4 Code J | —192,806 | filing |
| 14 Aug 2025filed 18 Aug 2025 | IART Integra LifeSciences HoldingsMedical Devices | SEC FORM 4 Code J | $2.7M200,000 at $13.62 | filing |
| 14 Aug 2025filed 18 Aug 2025 | IART Integra LifeSciences HoldingsMedical Devices | SEC FORM 4 Code J | $2.7M200,000 at $13.62 | filing |
| 1 Jul 2025filed 2 Jul 2025 | Dynatronics | SEC FORM 4 Code J | —870,203 | filing |
| 1 Jul 2025filed 2 Jul 2025 | Dynatronics | SEC FORM 4 Code J | —174,652 | filing |
The newest 500 lines are listed; the numbers count every line.
News
Citizens Jmp Has Lowered Expectations for Integra LifeSciences (NASDAQ:IART) Stock PriceIART · themarketsdaily.com · 22 Oct 2026Integra LifeSciences (NASDAQ:IART) Stock Gets Price Target Trim from JPMorgan Chase & Co.IART · dailypolitical.com · 22 Oct 2026FinancialContent - Why Integra LifeSciences (IART) stock is falling todayIART · financialcontent.com · 21 Oct 2026
0 headlines in the last 90 days name Stuart Essig; 3 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.